Literature DB >> 26564316

Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer.

Diletta Di Mitri1, Andrea Alimonti2.   

Abstract

Cellular senescence is a permanent growth arrest that is broadly recognized to act as a barrier against tumorigenesis. Senescence is predominant in premalignant tumors, and senescence escape is thought to be required for tumor progression. Importantly, evidences indicate that cell-autonomous mechanisms, such as genetic alterations or therapeutic interventions targeting specific genetic pathways, can affect the senescence response in cancer. Nevertheless, new findings have emerged in the last few years that indicate a fundamental role for the tumor microenvironment in the regulation of cellular senescence. Indeed, cytokines belonging to the senescent secretome, as well as tumor-infiltrating immune subsets, have been described to modulate the senescence response in tumors. Such evidence demonstrates that senescence initiation also relies on non-cell-autonomous mechanisms, which are discussed in the present review.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SASP; senescence; tumor immune microenvironment

Mesh:

Substances:

Year:  2015        PMID: 26564316     DOI: 10.1016/j.tcb.2015.10.005

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  28 in total

Review 1.  Caveolin-1, a master regulator of cellular senescence.

Authors:  Daniela Volonte; Ferruccio Galbiati
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

Review 2.  Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics.

Authors:  Nina Frey; Sascha Venturelli; Lars Zender; Michael Bitzer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-29       Impact factor: 46.802

3.  TLR4 Modulates Senescence and Paracrine Action in Placental Mesenchymal Stem Cells via Inhibiting Hedgehog Signaling Pathway in Preeclampsia.

Authors:  Yanqi Zhong; Yang Zhang; Weifang Liu; Yin Zhao; Li Zou; Xiaoxia Liu
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

Review 4.  Exploiting senescence for the treatment of cancer.

Authors:  Liqin Wang; Lina Lankhorst; René Bernards
Journal:  Nat Rev Cancer       Date:  2022-03-03       Impact factor: 69.800

5.  Polycomb and lung cancer: When the dosage makes the (kind of) poison.

Authors:  Gaetano Gargiulo; Elisabetta Citterio; Michela Serresi
Journal:  Mol Cell Oncol       Date:  2016-02-24

Review 6.  There are only four basic modes of cell death, although there are many ad-hoc variants adapted to different situations.

Authors:  Xingde Liu; Wenxiu Yang; Zhizhong Guan; Wenfeng Yu; Bin Fan; Ningzhi Xu; D Joshua Liao
Journal:  Cell Biosci       Date:  2018-02-01       Impact factor: 7.133

7.  Inhibition of SIRT1 Limits Self-Renewal and Oncogenesis by Inducing Senescence of Liver Cancer Stem Cells.

Authors:  Min-Jun Wang; Jia-Jia Chen; Shao-Hua Song; Jing Su; Ling-Hao Zhao; Qing-Gui Liu; Tao Yang; Zhiwen Chen; Chang Liu; Zhi-Ren Fu; Yi-Ping Hu; Fei Chen
Journal:  J Hepatocell Carcinoma       Date:  2021-06-29

Review 8.  "Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 Diabetes.

Authors:  Francesco Prattichizzo; Valeria De Nigris; Lucia La Sala; Antonio Domenico Procopio; Fabiola Olivieri; Antonio Ceriello
Journal:  Oxid Med Cell Longev       Date:  2016-06-01       Impact factor: 6.543

Review 9.  Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.

Authors:  Scott Haston; Saba Manshaei; Juan Pedro Martinez-Barbera
Journal:  J Endocrinol       Date:  2017-08-30       Impact factor: 4.286

10.  Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer.

Authors:  Min Hui Park; Jung Eun Choi; Jae-Ryong Kim; Young Kyung Bae
Journal:  Pathol Oncol Res       Date:  2021-06-29       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.